BAYRY Stock Recent News
BAYRY LATEST HEADLINES
Bayer AG (ETR:BAYN, OTC:BAYZF) has told US lawmakers it may halt sales of its popular Roundup weedkiller in the United States unless stronger legal protections are implemented to protect the company from ongoing product liability lawsuits, according to a Reuters report citing a source with knowledge of the matter. The German company has already paid about $10 billion to settle claims alleging that the herbicide glyphosate featured in Roundup causes cancer.
Bayer said on Friday it would seek shareholder approval to raise fresh equity capital worth close to 35% of its currently outstanding shares over the next three years to be ready for any U.S. litigation settlement.
Bayer has warned U.S. lawmakers it could stop selling the popular Roundup weedkiller if they cannot provide better legal protection against product liability litigation, according to a financial analyst and a person familiar with the matter.
BAYRY's fourth-quarter earnings match expectations. Revenues top estimates, driven by the strong performance of its pharmaceutical business.
Bayer Aktiengesellschaft (OTCPK:BAYZF) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Company Participants Jost Reinhard - IR Bill Anderson - Chairman & CEO Wolfgang Nickl - CFO Rodrigo Santos - President, Crop Science Division Julio Triana - President, Consumer Health Division Stefan Oelrich - President, Pharmaceuticals Division Conference Call Participants James Quigley - Goldman Sachs Richard Vosser - J.P. Morgan Steven Byrne - Bank of America Jo Walton - UBS Thibault Boutherin - Morgan Stanley Florent Cespedes - Sanford C.
On Wednesday, Bayer AG BAYRY reported fourth-quarter 2024 adjusted EPS of $0.28, missing the consensus of $1.00.
Bayer on Wednesday raised the prospect of a return to earnings growth next year after reiterating that a decline was expected for this year.
Bayer's CEO is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline this year, as the group prepares to release quarterly results on Wednesday.
February is American Heart Month - Expert with Bayer Discusses Key Risk Factors for Heart Disease and Shares Practical Tips for Improving Heart Health
February is American Heart Month - Expert with Bayer Discusses Key Risk Factors for Heart Disease and Shares Practical Tips for Improving Heart Health